Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e878a203c000404e831165b23d4609b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e878a203c000404e831165b23d4609b3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e878a203c000404e831165b23d4609b32021-11-11T07:43:34ZComprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders1664-802110.3389/fgene.2021.735454https://doaj.org/article/e878a203c000404e831165b23d4609b32021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.735454/fullhttps://doaj.org/toc/1664-8021Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6A methylation levels in blood from two groups: NMOSD patients and healthy controls. Methylated RNA immunoprecipitation Sequencing (MeRIP-seq) and RNA-seq were performed to assess differences in m6A methylation between NMOSD patients and healthy controls. Ultra-high performance liquid chromatography coupled with triple quadruple mass spectrometry (UPLC-QQQ-MS) method was performed to check m6A level. Differential m6A methylation genes were validated by MeRIP-qPCR.Results: Compared with that in the control group, the total m6A level was decreased in the NMOSD group. Genes with upregulated methylation were primarily enriched in processes associated with RNA splicing, mRNA processing, and innate immune response, while genes with downregulated methylation were enriched in processes associated with the regulation of transcription, DNA-templating, and the positive regulation of I-kappa B kinase/NF-kappa B signalling.Conclusion: These findings demonstrate that differential m6A methylation may act on functional genes to regulate immune homeostasis in NMOSD.Hong YangYi-Fan WuJie DingWei LiuDe-Sheng ZhuXia-Feng ShenYang-Tai GuanYang-Tai GuanFrontiers Media S.A.articleneuromyelitis optica spectrum disorderimmune homeostasisN6-methyladenosine (m6A) methylationdifferential methylation peaksMeRIP-seqUPLC-QQQ-MSGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
neuromyelitis optica spectrum disorder immune homeostasis N6-methyladenosine (m6A) methylation differential methylation peaks MeRIP-seq UPLC-QQQ-MS Genetics QH426-470 |
spellingShingle |
neuromyelitis optica spectrum disorder immune homeostasis N6-methyladenosine (m6A) methylation differential methylation peaks MeRIP-seq UPLC-QQQ-MS Genetics QH426-470 Hong Yang Yi-Fan Wu Jie Ding Wei Liu De-Sheng Zhu Xia-Feng Shen Yang-Tai Guan Yang-Tai Guan Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
description |
Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6A methylation levels in blood from two groups: NMOSD patients and healthy controls. Methylated RNA immunoprecipitation Sequencing (MeRIP-seq) and RNA-seq were performed to assess differences in m6A methylation between NMOSD patients and healthy controls. Ultra-high performance liquid chromatography coupled with triple quadruple mass spectrometry (UPLC-QQQ-MS) method was performed to check m6A level. Differential m6A methylation genes were validated by MeRIP-qPCR.Results: Compared with that in the control group, the total m6A level was decreased in the NMOSD group. Genes with upregulated methylation were primarily enriched in processes associated with RNA splicing, mRNA processing, and innate immune response, while genes with downregulated methylation were enriched in processes associated with the regulation of transcription, DNA-templating, and the positive regulation of I-kappa B kinase/NF-kappa B signalling.Conclusion: These findings demonstrate that differential m6A methylation may act on functional genes to regulate immune homeostasis in NMOSD. |
format |
article |
author |
Hong Yang Yi-Fan Wu Jie Ding Wei Liu De-Sheng Zhu Xia-Feng Shen Yang-Tai Guan Yang-Tai Guan |
author_facet |
Hong Yang Yi-Fan Wu Jie Ding Wei Liu De-Sheng Zhu Xia-Feng Shen Yang-Tai Guan Yang-Tai Guan |
author_sort |
Hong Yang |
title |
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
title_short |
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
title_full |
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
title_fullStr |
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
title_full_unstemmed |
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders |
title_sort |
comprehensive analysis of n6-methyladenosine (m6a) methylation in neuromyelitis optica spectrum disorders |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/e878a203c000404e831165b23d4609b3 |
work_keys_str_mv |
AT hongyang comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT yifanwu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT jieding comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT weiliu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT deshengzhu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT xiafengshen comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT yangtaiguan comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders AT yangtaiguan comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders |
_version_ |
1718439452312862720 |